Afdhal N - Search Results

1

Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis.

Hu K, Perez-Matos MC, Argemi J, Vilar-Gomez E, Shalaurova I, Bullitt E, Landeen L, Sugahara G, Deng H, Mathur K, Tran S, Cai H, He H, Yalcin Y, Vieira Barbosa J, Ventura-Cots M, Marx K, Gad AP, Niezen S, Izunza Barba S, Ang LH, Popov YV, Fricker Z, Lai M, Curry M, Afdhal N, Szabo G, Mukamal KJ, Sanyal AJ, Otvos JD, Malik R, Saito T, Connelly MA, Chalasani NP, Bataller R, Jiang ZG. Hu K, et al. Among authors: afdhal n. Hepatology. 2022 Apr;75(4):968-982. doi: 10.1002/hep.32203. Epub 2021 Dec 7. Hepatology. 2022. PMID: 34662439 Free PMC article.

2

Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

Graham CS, Curry M, He Q, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ. Graham CS, et al. Among authors: afdhal n. Hepatology. 2004 Jul;40(1):125-32. doi: 10.1002/hep.20258. Hepatology. 2004. PMID: 15239095

3

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH. Kelleher TB, et al. J Hepatol. 2005 Jul;43(1):78-84. doi: 10.1016/j.jhep.2005.02.025. Epub 2005 Apr 25. J Hepatol. 2005. PMID: 15894397

4

Use of growth factors with antiviral therapy for chronic hepatitis C.

Curry MP, Afdhal NH. Curry MP, et al. Clin Liver Dis. 2005 Aug;9(3):439-51, vii. doi: 10.1016/j.cld.2005.05.012. Clin Liver Dis. 2005. PMID: 16023976 Review.

5

Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis.

Kamal SM, Turner B, He Q, Rasenack J, Bianchi L, Al Tawil A, Nooman A, Massoud M, Koziel MJ, Afdhal NH. Kamal SM, et al. Hepatology. 2006 Apr;43(4):771-9. doi: 10.1002/hep.21117. Hepatology. 2006. PMID: 16557547

6

Duration of peginterferon therapy in acute hepatitis C: a randomized trial.

Kamal SM, Moustafa KN, Chen J, Fehr J, Abdel Moneim A, Khalifa KE, El Gohary LA, Ramy AH, Madwar MA, Rasenack J, Afdhal NH. Kamal SM, et al. Among authors: afdhal nh. Hepatology. 2006 May;43(5):923-31. doi: 10.1002/hep.21197. Hepatology. 2006. PMID: 16628640 Clinical Trial.

7

Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis.

Afdhal NH, Curry M. Afdhal NH, et al. J Hepatol. 2007 Apr;46(4):543-5. doi: 10.1016/j.jhep.2007.01.008. Epub 2007 Jan 29. J Hepatol. 2007. PMID: 17316879 Review. No abstract available.

8

Stiffness and impedance: the new liver biomarkers.

Malik R, Afdhal N. Malik R, et al. Among authors: afdhal n. Clin Gastroenterol Hepatol. 2007 Oct;5(10):1144-6. doi: 10.1016/j.cgh.2007.07.024. Clin Gastroenterol Hepatol. 2007. PMID: 17916542 No abstract available.

9

The clinical significance of persistently normal ALT in chronic hepatitis B infection.

Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. Lai M, et al. J Hepatol. 2007 Dec;47(6):760-7. doi: 10.1016/j.jhep.2007.07.022. Epub 2007 Sep 24. J Hepatol. 2007. PMID: 17928090

10

Liver masses and eosinophilia.

Lai M, Afdhal N, Challies T. Lai M, et al. Among authors: afdhal n. Liver Int. 2008 Jan;28(1):150. doi: 10.1111/j.1478-3231.2007.01587.x. Liver Int. 2008. PMID: 18173566 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters